FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Merck Reports Positive Data on HIV Trials

[ Price : $8.95]

Merck says it will seek FDA approval for new HIV regimen following its announcement of positive results from two pivotal Phase 3 t...

DoJ Lawyer Tapped as FDA Chief Counsel

[ Price : $8.95]

HHS appoints Justice Department attorney Hilary Perkins to serve as FDA chief counsel.

J&Js Monarch Quest Bronchoscopy Navigation Cleared

[ Price : $8.95]

FDA clears a Johnson & Johnson MedTech 510(k) for its Monarch Quest, an advanced navigation technology for robotically assisted br...

Comments Reopened on Good Clinical Practice Guide

[ Price : $8.95]

Federal Register notice: FDA reopens the comment period for its draft guidance entitled E6(R3) Good Clinical Practice: Annex 2.

Priority Review for DMD Cardiomyopathy BLA

[ Price : $8.95]

FDA accepts for priority review an NS Pharma BLA for deramiocel, an investigational cell therapy for Duchenne muscular dystrophy c...

Zenrelia Promotions False and Misleading: FDA

[ Price : $8.95]

FDA warns Elanco Animal Health that promotional materials for its Zenrelia are misbranded due to false and misleading representati...

FDA Safety Alert on Immune Globulin Products

[ Price : $8.95]

An FDA safety alert says several manufacturers have recalled several lots of immune globulin intravenous and subcutaneous products...

CGMP Deviations at Shree Jaya Unit

[ Price : $8.95]

FDA warns Indias Shree Jaya Laboratories about CGMP deviations in its production of active pharmaceutical ingredients at a facilit...

Linghai ZhanWang Records Show CGMP Violations

[ Price : $8.95]

FDA warns Chinas Linghai ZhanWang Biotechnology Co. about CGMP violations in its manufacturing of over-the-counter drugs.

Positive Data on Pfizer/Arvinas Breast Cancer Study

[ Price : $8.95]

Pfizer and Arvinas announce positive topline results from a clinical trial evaluating vepdegestrant monotherapy versus fulvestrant...